Skip to main content
Equibles

Clay Northam Wealth Management, LLC

Position in ARDX — Ardelyx, Inc.

CIK 1915687 HUNTINGTON BEACH, CA
Back to ARDX Full portfolio

Position in ARDX

as of Jun 30, 2026 · filed Aug 11, 2026
Position Value
$1,703,986
-$284,484 QoQ
Shares Held
334,115
+0.6% QoQ
Ownership
0.134%
of shares outstanding
% of Portfolio
1.69%
of 13F equity value
Holder Rank
#51
of 250 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in ARDX Over Time

Shares Held

Position Value (USD)

Derivatives in ARDX

reported options exposure · as of Dec 31, 2025
CallValue
$13,670
CallShares
19,500
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Clay Northam Wealth Management, LLC holds $1,703,986 across 1 Biotechnology name. ARDX ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ARDX
Ardelyx, Inc.
This page 		334,115 $1,703,986

All Filings in ARDX

Export CSV
12 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,703,986 334,115
2026-03-31 $1,988,470 331,965
2025-12-31 $1,836,537 315,015
2025-12-31 $13,670 19,500
2025-09-30 $1,782,292 323,465
2025-06-30 $1,339,522 341,715
2025-03-31 $1,706,004 347,455
2024-12-31 $1,559,937 307,680
2024-09-30 $1,939,342 281,472
2024-06-30 $1,721,913 232,377
2024-03-31 $665,993 91,232
2023-12-31 $381,932 61,602